1. |
Cascella M, Fiore M, Leone S, et al. Current controversies and future perspectives on treatment of intensive care unit delirium in adults. World J Crit Care Med, 2019, 8(3): 18-27.
|
2. |
Gunther ML, Morandi A, Ely EW. Pathophysiology of delirium in the intensive care unit. Crit Care Clin, 2008, 24(1): 45-65.
|
3. |
Pandharipande P, Cotton BA, Shintani A, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma, 2008, 65(1): 34-41.
|
4. |
Vasilevskis EE, Chandrasekhar R, Holtze CH, et al. The cost of ICU delirium and coma in the intensive care unit patient. Med Care, 2018, 56(10): 890-897.
|
5. |
Brummel NE, Jackson JC, Pandharipande PP, et al. Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit Care Med, 2014, 42(2): 369-377.
|
6. |
Kiely DK, Marcantonio ER, Inouye SK, et al. Persistent delirium predicts greater mortality. J Am Geriatr Soc, 2009, 57(1): 55-61.
|
7. |
Reiter RJ, Korkmaz A. Clinical aspects of melatonin. Saudi Med J, 2008, 29(11): 1537-1547.
|
8. |
Sletten TL, Magee M, Murray JM, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med, 2018, 15(6): e1002587.
|
9. |
Bjorvatn B, Saxvig I, Wilhelmsen-Langeland A, et al. A randomized controlled trial of the effects of bright light and melatonin for delayed sleep phase disorder. Sleep Med, 2013, 14(Supp_S1): e74-e75.
|
10. |
张燕平, 赵平. 褪黑素对老年女性患者术后早期认知功能障碍的影响. 中国医科大学学报, 2019, 48(5): 437-441.
|
11. |
Nishikimi M, Numaguchi A, Takahashi K, et al. Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: a single-center randomized placebo-controlled trial. Crit Care Med, 2018, 46(7): 1099-1105.
|
12. |
Abbasi S, Farsaei S, Ghasemi D, et al. Potential role of exogenous melatonin supplement in delirium prevention in critically ill patients: a double-blind randomized pilot study. Iran J Pharm Res, 2018, 17(4): 1571-1580.
|
13. |
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration, 2011. https://training.cochrane.org/handbook/archive/v5.1/.
|
14. |
Bellapart J, Appadurai V, Lassig-Smith M, et al. Effect of exogenous melatonin administration in critically ill patients on delirium and sleep: a randomized controlled trial. Crit Care Res Pract, 2020(3): 3951828.
|
15. |
Ford AH, Flicker L, Kelly R, et al. The healthy heart-mind trial: randomized controlled trial of melatonin for prevention of delirium. J Am Geriatr Soc, 2020, 68(1): 112-119.
|
16. |
Gandolfi JV, Di Bernardo A, Chanes D, et al. The effects of melatonin supplementation on sleep quality and assessment of the serum melatonin in ICU patients: a randomized controlled trial. Crit Care Med, 2020, 48(12): e1286-e1293.
|
17. |
Hatta K, Kishi Y, Wada K, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry, 2014, 71(4): 397-403.
|
18. |
Jaiswal SJ, Vyas AD, Heisel AJ, et al. Ramelteon for prevention of postoperative delirium: a randomized controlled trial in patients undergoing elective pulmonary thromboendarterectomy. Crit Care Med, 2019, 47(12): 1751-1758.
|
19. |
Kasnavieh FH, Rezaeipandari H, Hadadzadeh M, et al. Effect of melatonin on incidence rate of delirium in elderly patients undergoing open-heart surgery without a pump: a clinical trial. Elderly Health J, 2019, 5(1): 32-39.
|
20. |
Mistraletti G, Umbrello M, Sabbatini G, et al. Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial. Minerva Anestesiol, 2015, 81(12): 1298-1310.
|
21. |
Soltani F, Salari A, Javaherforooshzadeh F, et al. The effect of melatonin on reduction in the need for sedative agents and duration of mechanical ventilation in traumatic intracranial hemorrhage patients: a randomized controlled trial. Eur J Trauma Emerg Surg, 2020, 22: 1-7.
|
22. |
Vijayakumar HN, Ramya K, Duggappa DR, et al. Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: a double-blind randomised placebo controlled trial. Indian J Anaesth, 2016, 60(11): 814-820.
|
23. |
Kotfis K, Marra A, Ely EW. ICU delirium - a diagnostic and therapeutic challenge in the intensive care unit. Anaesthesiol Intensive Ther, 2018, 50(2): 160-167.
|
24. |
郭晋良, 王丹妮, 倪艳, 等. 基于褪黑素合成分泌探讨中医药改善睡眠的研究进展. 中华中医药学刊, 2021, 39(7): 99-102.
|
25. |
刘丹, 安友仲. 褪黑素与谵妄. 中华危重病急救医学, 2013, 25(6): 382-384.
|
26. |
郑清如, 卫婉蕊, 戈晓华. 成人谵妄相关生物标志物及其临床应用价值. 中国生物化学与分子生物学报, 2020, 36(11): 1288-1294.
|
27. |
孙婷, 韩芳, 孙运良, 等. 重症监护病房谵妄患者 24 h 连续睡眠监测及褪黑素动态水平变化的研究. 中华危重病急救医学, 2014, 26(10): 726-729.
|
28. |
熊照东, 潘学文, 朱卫东, 等. 术后血浆褪黑素水平与老年患者术后谵妄发生的相关性. 中国医师杂志, 2013, 15(7): 958-960.
|
29. |
Han Y, Wu J, Qin Z, et al. Melatonin and its analogues for the prevention of postoperative delirium: a systematic review and meta-analysis. J Pineal Res, 2020, 68(4): e12644.
|
30. |
黄定瑞. 渐进式早期康复训练对 ICU 机械通气病人谵妄、机械通气时间及 ICU 住院时间的影响. 全科护理, 2021, 19(4): 469-471.
|
31. |
Dessap AM, Roche-Campo F, Launay JM, et al. Delirium and circadian rhythm of melatonin during weaning from mechanical ventilation: an ancillary study of a weaning trial. Chest, 2015, 148(5): 1231-1241.
|
32. |
Khaing K, Nair BR. Melatonin for delirium prevention in hospitalized patients: a systematic review and meta-analysis. J Psychiatr Res, 2021, 133(4): 181-190.
|